Innovation in Biological Indicator Evaluator Resistometer Vessel Technology - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Innovation in Biological Indicator Evaluator Resistometer Vessel Technology
The authors examine advances in the design and the application of biological indicator evaluator resistometer vessels used to measure the resistance of bacterial spores in monitoring sterilization processes.


Pharmaceutical Technology



Table V: Fraction-negative D-values collected in triplicate on self-contained BI lot SC1 in three resistometers.
Fraction negative: self-contained BI. Fraction-negative data collected on the self-contained BI lot# SC1 are shown in Table V and Figure 11. Fraction-negative data collected on the self-contained BI lot SC2 are shown in Table VI and Figure 12. Fraction-negative data collected on the self-contained BI lot SC3 and SC4 are shown in Table VII.


Figure 11


Table VI: Fraction negative D-values collected in triplicate on self-contained BI lot SC2 in three resistometers.


Figure 12


Table VII. Fraction negative D-values collected on self-contained BI lots SC3 and SC4 in three resistometers.


Table VIII: Fraction negative D-values collected in triplicate on ampoule BI lot A1 in three resistometers.
Fraction negative: ampul BI. Fraction-negative data collected on the ampul BI lot A1 are shown in Table VIII and Figure 13.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here